Home » Stocks » 22nd Century Group

22nd Century Group, Inc. (XXII)

Stock Price: $0.75 0.01 (1.52%)
Today at 10:04 AM EST. Market open.

Stock Price Chart

Stock Quote

Trading Day Mar 30, 2020
Last Price $0.75
Change ($) 0.01
Change (%) 1.52%
Previous Close 0.74
Day's Open 0.74 (0.12%)
Day's Range 0.71 - 0.75
Day's Volume 78,691
52-Week Range 0.60 - 2.46

Key Info

Market Cap 106.41M
Revenue (ttm) 25.83M
Net Income (ttm) -26.56M
Shares Out 138.86M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE -5.11
Dividend n/a
Dividend Yield n/a

Key Stats and Metrics

Market Cap 106.41M
Enterprise Value 68.92M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 138.86M
Float 138.11M
EPS (basic) -0.21
EPS (diluted) -0.21
FCF / Share -0.12
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 16.58M
Short Ratio 7.42
Short % of Float 13.39%
Beta 1.56
PE Ratio n/a
Forward PE -5.11
P/FCF Ratio n/a
PS Ratio 4.12
PB Ratio 1.71
Revenue 25.83M
Operating Income -25.37M
Net Income -26.56M
Free Cash Flow -14.95M
Net Cash 37.49M
Net Cash / Share 0.26
Gross Margin 0.06%
Operating Margin -98.21%
Profit Margin -102.80%
FCF Margin -57.87%
ROA -18.55%
ROE -39.84%
ROIC -47.50%
Stats based on trailing-twelve-month (ttm) numbers.

Stock Analysis Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$11.5*
(1,432.72% upside)
Low
11.5
Current: 0.75
High
11.5
Target: 11.5
*Average 12-month price target from 1 stock analysts.

Financial Performance

Numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue25.8326.4316.6012.288.520.537.280.021.010.05
Revenue Growth-2.25%59.19%35.18%44.1%1510.99%-92.73%38666.35%-98.15%1933.06%-
Gross Profit0.010.90-0.71-0.43-0.580.036.82-0.050.590.02
Operating Income-25.37-24.02-13.30-11.39-12.04-10.591.81-3.24-3.76-1.10
Net Income-26.56-7.97-13.03-11.58-11.03-15.60-26.15-6.74-1.35-1.42
Shares Outstanding12612410179.8468.1459.9943.6430.4226.3912.44
Earnings Per Share-0.21-0.06-0.13-0.15-0.16-0.26-0.60-0.22-0.05-0.11
Operating Cash Flow-14.59-17.84-12.07-9.89-7.32-6.583.86-1.76-3.45-0.91
Capital Expenditures-0.36-0.45-1.16-0.20-0.040.42-3.45--0.01-
Free Cash Flow-14.95-18.29-13.23-10.08-7.36-6.160.40-1.76-3.46-0.91
Cash & Equivalents52.9559.4564.0014.494.987.725.830.000.260.00
Total Debt1.471.54-0.310.621.100.172.691.421.34
Net Cash / Debt51.4857.9164.0014.184.376.625.66-2.69-1.16-1.33
Assets68.9577.3079.7427.6418.3721.9512.292.642.392.80
Liabilities6.906.024.313.316.646.734.768.783.604.89
Book Value62.0571.2875.4324.3311.7315.227.52-6.13-1.22-2.09
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name 22nd Century Group, Inc.
Home Country United States
Employees 67

Stock Information

Ticker symbol XXII
Stock Exchange NYSE American
Sector Healthcare
Industry Drug Manufacturers

Description

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.